Methods Mol Biol 494, 177186, doi: 10.1007/9781597454193_10 (2008)
These medicines work on brain reward pathways and satiety signals, potentially reducing food cravings and binge episodes
The initial weeks of treatment are often focused on helping your body adjust to the medication
201801609 DOI: 10.1073/pnas.1801609115
As severe (grade3) gland atrophy, scanty lacy colloid, cell desquamation, vacuolization and inflammation were significantly the highest in group III (GLP group) (75%,62.5%,50%,75%) compared to (0%) in other groups (I, II, IV) respectively, also focal adenomatous changes were significantly higher in group III (GLP group) (62.5%) compared to (0%) in groups (I, and II) and (12.5%) in group (IV) respectively ( p = 0.037414, 0.037414,0.0027, 0.0455 & 0.038867, respectively) (Table 6